These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 31308344)

  • 21. Pooled efficacy and safety data for house dust mite sublingual immunotherapy tablets in adolescents.
    Matsuoka T; Bernstein DI; Masuyama K; Nolte H; Okamiya K; Seitzberg D; Nelson HS
    Pediatr Allergy Immunol; 2017 Nov; 28(7):661-667. PubMed ID: 28660739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The SQ House Dust Mite SLIT-Tablet Is Well Tolerated in Patients with House Dust Mite Respiratory Allergic Disease.
    Emminger W; Hernández MD; Cardona V; Smeenk F; Fogh BS; Calderon MA; de Blay F; Backer V
    Int Arch Allergy Immunol; 2017; 174(1):35-44. PubMed ID: 28950268
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 300 IR HDM tablet: a sublingual immunotherapy tablet for the treatment of house dust mite-associated allergic rhinitis.
    Demoly P; Okamoto Y; Yang WH; Devillier P; Bergmann KC
    Expert Rev Clin Immunol; 2016 Nov; 12(11):1141-1151. PubMed ID: 27632814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SQ house dust mite sublingual immunotherapy tablet subgroup efficacy and local application site reaction duration.
    Bernstein DI; Kleine-Tebbe J; Nelson HS; Bardelas JA; Sussman GL; Lu S; Rehm D; Svanholm Fogh B; Nolte H
    Ann Allergy Asthma Immunol; 2018 Jul; 121(1):105-110. PubMed ID: 29656145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Update on house dust mite immunotherapy: are more studies needed?
    Nelson HS
    Curr Opin Allergy Clin Immunol; 2014 Dec; 14(6):542-8. PubMed ID: 25115684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. House dust mite sublingual tablet is effective and safe in patients with allergic rhinitis.
    Okamoto Y; Fujieda S; Okano M; Yoshida Y; Kakudo S; Masuyama K
    Allergy; 2017 Mar; 72(3):435-443. PubMed ID: 27471838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppression of TIM-1 predicates clinical efficacy of sublingual immunotherapy for allergic rhinitis in children.
    Lin Z; Zhou L; Luo X; Xia W; Chen D; Xu R; Wang J; Luo R; Xu G; Li H
    Int J Pediatr Otorhinolaryngol; 2013 Aug; 77(8):1345-9. PubMed ID: 23800473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of leptin in allergic rhinitis during sublingual immunotherapy.
    Wen Y; Zhou L; Li Y; Li Z; Deng W; Zhang T
    Eur Arch Otorhinolaryngol; 2018 Nov; 275(11):2733-2738. PubMed ID: 30218387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SQ house dust mite (HDM) SLIT-tablet provides clinical improvement in HDM-induced allergic rhinitis.
    Klimek L; Mosbech H; Zieglmayer P; Rehm D; Stage BS; Demoly P
    Expert Rev Clin Immunol; 2016; 12(4):369-77. PubMed ID: 26788764
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epinephrine Use in Clinical Trials of Sublingual Immunotherapy Tablets.
    Nolte H; Casale TB; Lockey RF; Fogh BS; Kaur A; Lu S; Nelson HS
    J Allergy Clin Immunol Pract; 2017; 5(1):84-89.e3. PubMed ID: 27838323
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies.
    Calderon MA; Casale TB; Nelson HS; Demoly P
    J Allergy Clin Immunol; 2013 Dec; 132(6):1322-36. PubMed ID: 24139829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sublingual Immunotherapy Decreases Expression of Interleukin-33 in Children with Allergic Rhinitis.
    Wang Y; Li C; Xu Y; Xu D; Yang G; Liao F; Luo X
    Indian J Pediatr; 2018 Oct; 85(10):872-876. PubMed ID: 29790007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo and in vitro studies of Th17 response to specific immunotherapy in house dust mite-induced allergic rhinitis patients.
    Li CW; Lu HG; Chen DH; Lin ZB; Wang DY; Li TY
    PLoS One; 2014; 9(3):e91950. PubMed ID: 24647473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of SQ house dust mite sublingual immunotherapy-tablet in Japanese children.
    Masuyama K; Okamoto Y; Okamiya K; Azuma R; Fujinami T; Riis B; Ohashi-Doi K; Natsui K; Imai T; Okubo K
    Allergy; 2018 Dec; 73(12):2352-2363. PubMed ID: 30043449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sublingual immunotherapy (SLIT) for house dust mites does not prevent new allergen sensitization and bronchial hyper-responsiveness in allergic rhinitis children.
    Lim JH; Kim JY; Han DH; Lee CH; Hong SN; Wee JH; Park SK; Rhee CS
    PLoS One; 2017; 12(8):e0182295. PubMed ID: 28806766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-minimization analysis of sublingual immunotherapy versus subcutaneous immunotherapy for house dust mite respiratory allergic disease in Denmark.
    Rønborg S; Johnsen CR; Theilgaard S; Winther A; Hahn-Pedersen J; Andreasen JN; Olsen J
    J Med Econ; 2016 Aug; 19(8):735-41. PubMed ID: 26909663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sublingual immunotherapy tablets as a disease-modifying add-on treatment option to pharmacotherapy for allergic rhinitis and asthma.
    Brunton S; Nelson HS; Bernstein DI; Lawton S; Lu S; Nolte H
    Postgrad Med; 2017 Aug; 129(6):581-589. PubMed ID: 28326908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety of house dust mite sublingual immunotherapy standardized quality tablet in children allergic to house dust mites.
    Maloney J; Prenner BM; Bernstein DI; Lu S; Gawchik S; Berman G; Kaur A; Li Z; Nolte H
    Ann Allergy Asthma Immunol; 2016 Jan; 116(1):59-65. PubMed ID: 26553448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of sublingual immunotherapy for house dust mite allergic rhinitis.
    Cingi C; Bayar Muluk N; Ulusoy S; Acar M; Şirin S; Çobanoğlu B; Birdane L; Kalaycık Ç; Çakır BÖ; Oğhan F; Aynacı S; Erdoğmuş N; Yıldırım Ö; Şahin E; Bulut F; Aksoy MA; Türe N; Bal C
    Eur Arch Otorhinolaryngol; 2015 Nov; 272(11):3341-6. PubMed ID: 25516223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of sublingual dust mite drops in children with mono- or polysensitized allergic rhinitis.
    Zhang YZ; Luo J; Wang ZH; Wang J
    Am J Otolaryngol; 2019; 40(5):755-760. PubMed ID: 31327579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.